Skip to content

A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)

A Prospective Randomized Comparison of the Adenoma Detection Rate in Screening Colonoscopy With and Without a Disposable Cap (ENDOCUFF VISION®)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03442738
Acronym
Endocuff
Enrollment
1382
Registered
2018-02-22
Start date
2017-09-01
Completion date
2022-09-30
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Detection Rate

Keywords

ADR, adenoma, polyp, colon, screening, colorectal carcinoma (CRC), cap, endoscopy, colonoscopy, private practice

Brief summary

The aim of this study is to evaluate the effect of ENDOCUFF VISION® (caps with soft, about 1 cm long lateral feet of rubber (Endocuff) to flatten the colon folds) on ADR in a real-life setting (general practices) and in a homogenous patient collective (screening colonoscopies only). It is a prospective randomized multi centric study, with participation of at least 10 study sites (private practice). The study is an inverstigator-initiated trial (IIT). Depending on the randomization (closed envelope), the patients are examined with the standard instruments without or with ENDOCUFF VISION®. Group 1: screening colonoscopy with standard colonoscopes with ENDOCUFF VISION® Group 2: screening colonoscopy with standard colonoscopes without cap

Detailed description

Colonoscopy is currently the best method for the detection of colon carcinomas and, as precursor, adenomas, since these can also be biopsied and removed. Therefore, the screening colonoscopy was introduced at the end of 2002 (covered by state insurance) from the age of 55. The main quality parameter for outcome quality is the adenoma detection rate (ADR), which correlates with the rate of the carcinomas prevented. However, since even smaller polyps, especially if they are flat or sunken, may be relevant for colon cancer development, the aim of colonoscopy should be to be able to recognize and remove as many adenomas as possible. There is a need to optimize the efficiency of screening colonoscopy by increasing the rate of adenoma detection, as it is known from many studies that approximately 15-30% of adenomas can be missed- even though the adenoma rate in the German screening colonoscopy register continues to increase over the years and currently stands at 28%. Previous studies on the increase of the adenoma detection rate by endoscopy concerning newer endoscope technologies including conventional caps have been almost entirely negative. For about 2 years, a newer version of ENDOCUFF VISION® caps (caps with soft, about 1 cm long lateral feet of rubber (Endocuff) to flatten the colon folds) is available which has already been used in about 8,000 colonoscopies in Germany and another 10,000 colonoscopies in Europe; there are no studies on this version of Endocuff caps. The aim of this study is to evaluate the effect of ENDOCUFF VISION® in a real-life setting (general practices) and in a homogenous patient collective (screening colonoscopies only). It is a prospective randomized multi centric study, with participation of at least 10 study sites (private practice). The study is an inverstigator-initiated trial (IIT). A new technique for ADR improvement within colonoscopy can only be tested in a comparative study in two groups comparing the adenoma rate between the two groups. An independent gold standard does not exist in this sense, but the confirmation by the endoscopically taken histology serves as gold standard for the diagnosis adenoma. The alternative of double examinations (tandem colonoscopy) in each patient is in the setting of private practice not feasible. Depending on the randomization (closed envelope), the patients are examined with the standard instruments without or with ENDOCUFF VISION®. Group 1: screening colonoscopy with standard colonoscopes with ENDOCUFF VISION® Group 2: screening colonoscopy with standard colonoscopes without cap

Interventions

PROCEDUREEndocuff group

Endocuff Vision cap on Standard colonoscope

Sponsors

Norgine
CollaboratorINDUSTRY
Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 55 years * who voluntarily undergo a screening colonoscopy * information and signed declaration of consent

Exclusion criteria

* symptoms that may indicate a colonic disease * rectal/colonic bleeding * known colon disease for further diagnosis, e.g. Carcinoma, polyps for erosion, inflammatory bowel disease, stenosis * follow-up/surveillance after colon carcinoma surgery or polypectomy * anticoagulant drugs that make a biopsy or polypectomy impossible * poor general condition (from ASA (American Society of Anesthesiologists Classification) III) * partial/incomplete colonoscopy planned

Design outcomes

Primary

MeasureTime frameDescription
Adenoma Detection Rate (ADR) in the two study groupsthrough study completion, an average of 1 yearDifferences in ADR with or without the new disposable ENDOCUFF VISION® cap. Hypothesis: Endocuff Vision improves the adenoma detection rate (ADR) by about 25% compared to the comparison group.

Secondary

MeasureTime frameDescription
assessment of adenoma subgroups by location12 monthsdifferences in adenoma subgroups (between intestinal folds with good accessibility, between intestinal folds with poor accessibility, on top of intestinal fold, behind intestinal fold )
assessment of adenoma subgroups by size12 monthsmeasured by comparison with size of snare or forceps
assessment of adenoma subgroups by form12 monthsstem-based, broad-based, flat adenoma
assessment of adenoma subgroups by histology12 monthsloiw grade intraepithelial neoplasia (LGIN), high grade intraepithelial neoplasia (HGIN), sessile serrated Adenoma (SSA), Carcinoma
ADR (all adenoma/all patients)12 monthsADR (all adenoma/all patients)
assessment of adenoma subgroups by resection practice12 monthsresection of adenoma by biopsy, polypectomy, resection by forceps, none
Intervention timesthrough study completion, an average of 1 yearduration of Intervention
procedure techniquethrough study completion, an average of 1 yeartechnical aspects of polypectomy/biopsy
assessment of adenoma subgroups by adjustability12 monthsadjustability of adenoma by colonoscope on a score scale from 1(very good) - 6 (poor)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026